Cocrystal Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COCP and other ETFs, options, and stocks.About COCP
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies to create first- and best-in-class antiviral drugs.
CEOSam Lee
CEOSam Lee
Employees11
Employees11
HeadquartersBothell, Washington
HeadquartersBothell, Washington
Founded2008
Founded2008
Employees11
Employees11
COCP Key Statistics
Market cap13.61M
Market cap13.61M
Price-Earnings ratio-1.05
Price-Earnings ratio-1.05
Dividend yield—
Dividend yield—
Average volume56.16K
Average volume56.16K
High today$1.03
High today$1.03
Low today$0.97
Low today$0.97
Open price$1.02
Open price$1.02
Volume112.14K
Volume112.14K
52 Week high$3.26
52 Week high$3.26
52 Week low$0.90
52 Week low$0.90
Stock Snapshot
As of today, Cocrystal Pharma(COCP) shares are valued at $0.99. The company's market cap stands at 13.61M, with a P/E ratio of -1.05.
During the trading session on 2025-12-17, Cocrystal Pharma(COCP) shares reached a daily high of $1.03 and a low of $0.97. At a current price of $0.99, the stock is +2.1% higher than the low and still -3.9% under the high.
Trading volume for Cocrystal Pharma(COCP) stock has reached 112.14K, versus its average volume of 56.16K.
The stock's 52-week range extends from a low of $0.90 to a high of $3.26.
The stock's 52-week range extends from a low of $0.90 to a high of $3.26.
People also own
Based on the portfolios of people who own COCP. This list is generated using Robinhood data, and it’s not a recommendation.